WSAAI 59th Annual Scientific Session

Program Summary

 

Activity Information

2021 Annual Scientific Session
Fairmont Orchid, Big Island, HI
March 14-18, 2021

Target Audience

Practicing allergists and allied health care providers in the field of allergy and immunology.

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the American College of Allergy, Asthma & Immunology (ACAAI) and the Western Society of Allergy, Asthma and Immunology (WSAAI).   The American College of Allergy, Asthma and Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Joint Providership

 

Jointly Provided by the American College of Allergy, Asthma & Immunology and the Western Association of Allergy, Asthma & Immunology.

Commercial Support

This activity is supported by commercial interests.

Learning Objectives

  1. Recognize the different monoclonal antibody therapies for severe asthma and future agents in the drug pipeline
  2. Learn how gastroenterologists approach patients with mast cell disorders
  3. Recognize the current and potential roles of biologics to treat chronic rhinosinusitis
  4. Follow a world-expert in primary immunodeficiencies on how she approaches the diagnosis and treatment of PIDD
  5. Recognize the benefit working with gastroenterologists in co-managing inflammatory conditions like Eosinophilic Esophagitis (EoE).
  6. Discover novel triggers for hypersensitivity skin diseases such as contact dermatitis
  7. Recognize how allergists can actively treat food allergies.

 

Disclosure Policy

As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all educational planners, presenters, instructors, moderators, authors, reviewers, and other individuals in a position to control or influence the content of an activity must disclose all financial relationships with any commercial interest that have occurred within the past 12 months.  The ACCME considers relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.

All identified conflicts of interest must be resolved and the educational content fully vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. It is required that the disclosures be provided to the learners prior to the start of the activity.  Individuals with no financial relationships to disclose must also inform the learners that no financial relationships exist.

Learners must also be informed with off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials.

Disclosure in no way implies that the information presented is biased or of lesser quality.  It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations.

Expressed views do not necessarily reflect the opinions of the ACAAI.

Satellite Activities

Industry led lectures and exhibits will be conducted as optional learning opportunities in conjunction with this event. These optional activities are not certified for CME credit and are not planned or sanctioned by the American College of Allergy, Asthma and Immunology or WSAAI.

Planning Committee

The Board of Directors of the Western Society of Allergy, Asthma and Immunology (WSAAI) serves as the Planning Committee for the Educational Meeting. The Board includes the following physicians: Jennifer Namazy, M.D.; Matthew Bowdish, M.D.; Steven Machtinger, M.D.; Rene Anderson-Cowell, M.D.; David Elkayam, M.D.; Andrew White, M.D.; Neal Jain, M.D.; Marc Riedl, M.D., M.S.

ADA Statement

in compliance with the Americans with Disabilities Act, WSAAI requests that any participant in need of accommodation send email to: karol@wsaai.org

Schedule

6:45a - WELCOME AND INTRODUCTION: Steve Machtinger, MD, Program Director/President Elect SESSION MODERATOR: Matthew Bowdish, MD, President

7:00a - The Donald Stevenson, MD Lecture: AERD by Dave Khan, MD

8:00a - Stress, Anxiety and Depression in Allergy and Asthma Patients by Gailen Marshall, MD, PhD

9:00a - The Long-term Consequences of Childhood Asthma by Leonard Bacherier, MD

10:00a - BREAK/EXHIBITS/POSTERS

10:30a - Factors Effecting Efficacy and Safety of Sublingual Immunotherapy by Hal Nelson, MD

11:30a - Tales of a Rash Whisperer: Untangling the Mystery of Adult Recalcitrant Eczematous Dermatitis by Jenny Murase, MD

12:00p - EXHIBITS

12:30p - SESSION MODERATOR: Rene Anderson-Cowell, MD Secretary/Treasurer

12:40p - The Harold S. Nelson, MD Lecture: Biologics in Asthma - Is Disease Remission Possible? by Jonathan Corren, MD

1:40p - Eosinophilic Esophagitis, Gastritis and Gastroenteritis by Seema Aceves, MD, PhD

2:40p - Oral Allergy Syndrome by Matt Greenhawt, MD

3:40p - BREAK/EXHIBITS/POSTERS

4:10p - CVID by Troy Torgerson, MD, PhD

4:40p - Specific Antibody Deficiency in Chronic Sinusitis? Myth or Reality by Larry Borish, MD

7:00a - WSAAI MEMBER BREAKFAST/BUSINESS MEETING EXIBITS/BREAK/POSTERS

8:00a - SESSION MODERATOR: Jennifer Namazy, MD Immediate Past President The History and Evolution of Allergy Immunotherapy by Hal Nelson, MD

8:30a - Drug Allergy Parameters Update by Dave Khan, MD

9:30a - Adult Atopic Dermatitis: To Patch, or not to Patch, that is the Question by Jenny Murase, MD

11:30a - BREAK

12:00p - Phenotype Directed Therapy in Preschool Asthma by Leonard Bacharier, MD

1:00p - Addressing Psychological Dysfunction in Allergy and Asthma Patients: Office-based Therapeutic Option by Gailen Marshall, MD, PhD

2:00p - 4:00p - Workshop by Speakers TBD

11:30a - EXHIBITS/POSTERS

12:00p - SESSION MODERATOR by Steve Machtinger, MD Program Director/President Elect

12:30p - EoE Treatment: Where Are We Now? by Seema Aceves, MD, PhD

1:30p - Prevention of Food Allergy by Matt Greenhawt, MD

2:30p - Fungal Syndromes in Asthma - Is it Time for a New Treatment Paradigm? by Jonathan Corren, MD

3:30p - BREAK/EXHIBITS/POSTERS

4:00p - Innate Immunity by Troy Torgerson, MD, PhD

5:00p - “Tasting” viruses - Chemosensory Cells in the Pathogenesis of Rhinovirus- mediated Asthma Exacerbations by Larry Borish, MD

6:30p - 8:30p - FAREWELL RECEPTION

Faculty

The WSAAI has assembled a world-class faculty for the 2021 Annual Meeting.

Seema Aceves, MD, PhD

  • Eosinophilic Esophagitis, Gastritis and Gastroenteritis
  • EoE Treatment: Where Are We Now?

Leonard Bacherier, MD

  • The Long-term Consequences of Childhood Asthma
  • Phenotype Directed Therapy in Preschool Asthma

Larry Borish, MD

  • Specific Antibody Deficiency in Chronic Sinusitis? Myth or Reality
  • “Tasting” viruses - Chemosensory Cells in the Pathogenesis of Rhinovirus- mediated Asthma Exacerbations

Jonathan Corren, MD

  • The Harold S. Nelson, MD Lecture: Biologics in Asthma - Is Disease Remission Possible?
  • Fungal Syndromes in Asthma - Is it Time for a New Treatment Paradigm?

Matt Greenhawt, MD

  • Oral Allergy Syndrome
  • Prevention of Food Allergy

Dave Khan, MD

  • The Donald Stevenson, MD Lecture: AERD
  • Drug Allergy Parameters Update

Gailen Marshall, MD, PhD

  • Stress, Anxiety and Depression in Allergy and Asthma Patients
  • Addressing Psychological Dysfunction in Allergy and Asthma Patients: Office-based Therapeutic Option

Jenny Murase, MD

  • Tales of a Rash Whisperer: Untangling the Mystery of Adult Recalcitrant Eczematous Dermatitis
  • Adult Atopic Dermatitis: To Patch, or not to Patch, that is the Question

Hal Nelson, MD

  • Factors Effecting Efficacy and Safety of Sublingual Immunotherapy
  • The History and Evolution of Allergy Immunotherapy

Troy Torgerson, MD, PhD

  • CVID
  • Innate Immunity